Yakira Capital Management Inc. purchased a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 10,603 shares of the company’s stock, valued at approximately $153,000.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Sit Investment Associates Inc. raised its position in shares of BlackRock Health Sciences Term Trust by 7.9% in the 4th quarter. Sit Investment Associates Inc. now owns 1,724,706 shares of the company’s stock valued at $24,836,000 after buying an additional 125,599 shares in the last quarter. Raymond James Financial Inc. bought a new position in BlackRock Health Sciences Term Trust in the fourth quarter valued at approximately $10,869,000. Stifel Financial Corp raised its position in BlackRock Health Sciences Term Trust by 2.2% during the third quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock valued at $6,563,000 after purchasing an additional 8,843 shares in the last quarter. Absolute Investment Advisers LLC bought a new stake in BlackRock Health Sciences Term Trust during the fourth quarter worth $3,941,000. Finally, Wolverine Asset Management LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 496.1% in the 4th quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock valued at $2,702,000 after purchasing an additional 156,141 shares in the last quarter.
BlackRock Health Sciences Term Trust Trading Down 5.0 %
Shares of BMEZ opened at $13.60 on Friday. BlackRock Health Sciences Term Trust has a 52-week low of $13.52 and a 52-week high of $16.75. The business’s fifty day moving average is $15.59 and its 200-day moving average is $15.53.
BlackRock Health Sciences Term Trust Cuts Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Airline Stocks – Top Airline Stocks to Buy Now
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to Invest in Small Cap Stocks
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.